Animal trial backs use of RTI's BioCleanse process
This article was originally published in Clinica
Executive Summary
The BioCleanse tissue sterilisation process, developed by RTI Biologics, allows meniscal allografts to perform to the same standard as those that underwent standard aseptic processing, a trial has shown.